Platelet
. Previous experience has indicated that DDAVP has no effect on the hematocrit and platelet count in blood from these patients (unpublished results). 
Assays ofFVIII-vWF-Related Properties

Normal Individuals
RESULTS
Administration
of DDAVP to normal individuals gave a two to fourfold increase of all FVIII-vWFrelated properties ( Table  2 ). The bleeding time values were not affected (Fig 1A) , but the platelet adherence was significantly enhanced (P < .025) after DDAVP infusion, and remained so for 90 minutes (Fig 1 B) .
A transient increase of platelet aggregate growth was also observed (Fig 1C) Tables  1 and 2 ). Experimental conditions were as given in Materials and Methods.
fold (Table  2) . In patient C.I., FVIIIR:RCF remained below the detection limit of the method (<6 U/dL). In all patients, however, the subnormal platelet adherence was enhanced by DDAVP administration, reaching levels above the normal range (Fig I E) (Fig 2A) . This was in parallel with a slightly enhanced platelet adherence in the blood from both patients, although not normalized (Fig 2B) . --------.G"p (Table  2 and Fig 2D) . 
DISCUSSION
